AU5323096A - Substituted 6-azacholesten-3-ones - Google Patents

Substituted 6-azacholesten-3-ones

Info

Publication number
AU5323096A
AU5323096A AU53230/96A AU5323096A AU5323096A AU 5323096 A AU5323096 A AU 5323096A AU 53230/96 A AU53230/96 A AU 53230/96A AU 5323096 A AU5323096 A AU 5323096A AU 5323096 A AU5323096 A AU 5323096A
Authority
AU
Australia
Prior art keywords
azacholesten
ones
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53230/96A
Inventor
Stephen Vernon Frye
Curt Dale Haffner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of AU5323096A publication Critical patent/AU5323096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53230/96A 1995-03-31 1996-03-25 Substituted 6-azacholesten-3-ones Abandoned AU5323096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506678.3A GB9506678D0 (en) 1995-03-31 1995-03-31 Substituted 6-azacholesten-3-ones
GB9506678 1995-03-31
PCT/US1996/004042 WO1996030391A1 (en) 1995-03-31 1996-03-25 Substituted 6-azacholesten-3-ones

Publications (1)

Publication Number Publication Date
AU5323096A true AU5323096A (en) 1996-10-16

Family

ID=10772263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53230/96A Abandoned AU5323096A (en) 1995-03-31 1996-03-25 Substituted 6-azacholesten-3-ones

Country Status (3)

Country Link
AU (1) AU5323096A (en)
GB (1) GB9506678D0 (en)
WO (1) WO1996030391A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704933B2 (en) * 1995-10-19 1999-05-06 Merck & Co., Inc. 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors
US6461596B1 (en) * 1997-02-18 2002-10-08 Andrea Taylor Composition and method for promoting hair growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480950B1 (en) * 1989-07-07 1999-03-24 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
NZ241979A (en) * 1991-03-20 1996-01-26 Merck & Co Inc Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
WO1993023419A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
AU4258493A (en) * 1992-05-21 1993-12-13 Endorecherche Inc. Inhibitors of testosterone 5alpha-reductase activity
AP459A (en) * 1992-12-18 1996-02-14 Glaxo Wellcome Inc Substituted 6-azaandrostenones.
US5438061A (en) * 1993-07-16 1995-08-01 Merck & Co., Inc. 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors
US5516779A (en) * 1994-06-08 1996-05-14 Merck & Co., Inc. 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors

Also Published As

Publication number Publication date
WO1996030391A1 (en) 1996-10-03
GB9506678D0 (en) 1995-05-24

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU6304196A (en) Substituted cyanophenyluracils
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6235496A (en) Azothiophenes
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU4382896A (en) Acetylimidazobenzodiazepines
AU5500196A (en) Anti-transpirants
AU6304396A (en) Substituted carbonylaminophenyluracils
AU5108596A (en) Morphine-3-esters
AU7038196A (en) 1-azinyl-tetrazolinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU6840796A (en) Sack-holder
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6658696A (en) Substituted phenyluracils
AU7565396A (en) Fluorobutenoyloxyacetamides
AU7694696A (en) Cyclopeptolides
AU6658396A (en) Polyhydroxyalkylamidobetaine